BRIEF-Celldex Therapeutics Q3 loss per share $0.20 By: Reuters: Company News November 07, 2017 at 09:29 AM EST * Q3 earnings per share view $-0.27 -- Thomson Reuters I/B/E/S Read More >> Related Stocks: Celldex Therapeutics